Cargando…
ASA Allergy and Desensitization Protocols in the Management of CAD: A Review of Literature
Acetylsalicylic acid (ASA) hypersensitivity still represents one of the major deals for patients with atherosclerotic cardiovascular disease (ASHD), especially for those requiring percutaneous coronary interventions in the absence of validated alternative options. Despite symptoms after ASA administ...
Autores principales: | Verdoia, Monica, Gioscia, Rocco, Nardin, Matteo, De Luca, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488748/ https://www.ncbi.nlm.nih.gov/pubmed/37685694 http://dx.doi.org/10.3390/jcm12175627 |
Ejemplares similares
-
Optimal dual antiplatelet therapy strategy in elderly patients with acute coronary syndrome
por: Verdoia, Monica, et al.
Publicado: (2021) -
Updates on the Management of STEMI in 2021: Beyond COVID-19
por: Verdoia, Monica, et al.
Publicado: (2022) -
Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease
por: Verdoia, Monica, et al.
Publicado: (2021) -
Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab
por: Bertlich, Mattis, et al.
Publicado: (2021) -
New Insights into Pathophysiology and New Risk Factors for ACS
por: Nardin, Matteo, et al.
Publicado: (2023)